The Jackson Laboratory—West: Special Symposium videos
Did you miss the Special Symposium and Grand Opening of The Jackson Laboratory—West, held in Sacramento, Calif. on May 5 and 6? If so, you can view many of the presentations through the links below. Thank you to our symposium speakers for their participation and for making their presentations available to the broader biomedical community. We also thank all of our sponsors for making these events possible through their generous support.
Symposium presentations
Using Mouse Models to Accelerate Translational Medicine and Drug Development
The focus of this special symposium was on the use of mouse models to advance human translational medicine and expedite drug development timelines. Topics included: the evolution of mouse genetics as a systems genetics tool; using JAX® Mice as research tools; using mice for drug discovery and development; humanized mouse models; and more.
Richard P. Woychik, Ph.D.
President and CEO, The Jackson Laboratory
Evolution of Mouse Genetics as a Systems Genetics Tool
Paul Watkins, M.D.
Director, Hamner-UNC Center for Drug Safety Sciences, University of North Carolina at Chapel Hill, NC Using Panels of Mice to Study Rare Adverse Drug Effects
Mathew Pletcher, Ph.D.
Senior Principal Scientist, Investigative Toxicology, Pfizer Global Research and Development Using Inbred Mouse Genomics to Better Understand Variable Efficacy and Safety of Pharmaceutical Therapies
Gregory Cox, Ph.D.
Associate Professor, The Jackson Laboratory
Engineered Models on Diverse Backgrounds to Model Human Disease
Norman M. Greenberg, Ph.D.
Member and Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center Mouse Models and Prostate Cancer: New Opportunities for Discovery
Allan Balmain, Ph.D.
Co-Leader, Cancer Genetics Program, and Director, Genome Analysis Core Facility, UCSF Helen Diller Family Comprehensive Cancer Center
Genetic Networks and Cancer Susceptibility in the Mouse
I-Ming Wang, Ph.D.
Associate Scientific Director, Molecular Profiling, Rosetta Inpharmatics, LLC
Systems Biology Analysis of Multiple Rodent Disease Models and Human Cancer Cohorts for Identification of New Targets and Biomarkers
Derry Roopenian, Ph.D.
Professor, The Jackson Laboratory
Using Mice for Drug Discovery and Development
Leonard Shultz, Ph.D.
Professor, The Jackson Laboratory Development of Humanized Mice for Biomedical Research
Frank Gonzales, Ph.D.
Head, Nucleic Acids Section, Laboratory Chief, NCI-Bethesda
P450 and Nuclear Receptor Humanized Mice to Study Drug Metabolism and Toxicity
Neal Goodwin, Ph.D.
In Vivo Cancer Program Director, The Jackson Laboratory—West Human Clinical Trials in the Mouse
Pier Paolo Pandolfi, M.D., Ph.D.
Director, Cancer Genetics Program, Beth Israel Deaconess Medical Center, Harvard University The APL Paradigm and the Co-Clinical Trial Project
Leon Hall, Ph.D.
In Vivo Core Program Director, The Jackson Laboratory—West Choosing the Right Mouse Model
Jan Nolta, Ph.D.
Director of the Stem Cell Program, UC Davis School of Medicine Using Immune Deficient Mice to Advance Toward Clinical Trials of Stem Cell Therapy
Mahendra S. Rao, M.D., Ph.D.
Adjunct Faculty Member, Buck Institute for Age Research Human Stem Cells in Mice
